Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer

NCT05841381 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

876

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pyrotinib
DRUG: Trastuzumab
DRUG: Paclitaxel

Sponsor

Fudan University